Global Female Contraceptive Market Insights and Forecast to 2031

Report ID: 1380092 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Female Contraceptive Product Introduction
    1.2 Market by Type
        1.2.1 Global Female Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Female Contraceptive Devices
        1.2.3 Female Contraceptive Drugs
    1.3 Market by Application
        1.3.1 Global Female Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Online Stores
        1.3.3 Retail Outlets
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Female Contraceptive Sales Estimates and Forecasts 2017-2028
    2.2 Global Female Contraceptive Revenue Estimates and Forecasts 2017-2028
    2.3 Global Female Contraceptive Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Female Contraceptive Sales by Region
        2.4.1 Global Female Contraceptive Sales by Region (2017-2022)
        2.4.2 Global Sales Female Contraceptive by Region (2023-2028)
    2.5 Global Female Contraceptive Revenue by Region
        2.5.1 Global Female Contraceptive Revenue by Region (2017-2022)
        2.5.2 Global Female Contraceptive Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Female Contraceptive Sales by Manufacturers
        3.1.1 Global Top Female Contraceptive Manufacturers by Sales (2017-2022)
        3.1.2 Global Female Contraceptive Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Female Contraceptive in 2021
    3.2 Global Female Contraceptive Revenue by Manufacturers
        3.2.1 Global Female Contraceptive Revenue by Manufacturers (2017-2022)
        3.2.2 Global Female Contraceptive Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Female Contraceptive Revenue in 2021
    3.3 Global Female Contraceptive Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Female Contraceptive Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Female Contraceptive Sales by Type
        4.1.1 Global Female Contraceptive Historical Sales by Type (2017-2022)
        4.1.2 Global Female Contraceptive Forecasted Sales by Type (2023-2028)
        4.1.3 Global Female Contraceptive Sales Market Share by Type (2017-2028)
    4.2 Global Female Contraceptive Revenue by Type
        4.2.1 Global Female Contraceptive Historical Revenue by Type (2017-2022)
        4.2.2 Global Female Contraceptive Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Female Contraceptive Revenue Market Share by Type (2017-2028)
    4.3 Global Female Contraceptive Price by Type
        4.3.1 Global Female Contraceptive Price by Type (2017-2022)
        4.3.2 Global Female Contraceptive Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Female Contraceptive Sales by Application
        5.1.1 Global Female Contraceptive Historical Sales by Application (2017-2022)
        5.1.2 Global Female Contraceptive Forecasted Sales by Application (2023-2028)
        5.1.3 Global Female Contraceptive Sales Market Share by Application (2017-2028)
    5.2 Global Female Contraceptive Revenue by Application
        5.2.1 Global Female Contraceptive Historical Revenue by Application (2017-2022)
        5.2.2 Global Female Contraceptive Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Female Contraceptive Revenue Market Share by Application (2017-2028)
    5.3 Global Female Contraceptive Price by Application
        5.3.1 Global Female Contraceptive Price by Application (2017-2022)
        5.3.2 Global Female Contraceptive Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Female Contraceptive Market Size by Type
        6.1.1 North America Female Contraceptive Sales by Type (2017-2028)
        6.1.2 North America Female Contraceptive Revenue by Type (2017-2028)
    6.2 North America Female Contraceptive Market Size by Application
        6.2.1 North America Female Contraceptive Sales by Application (2017-2028)
        6.2.2 North America Female Contraceptive Revenue by Application (2017-2028)
    6.3 North America Female Contraceptive Market Size by Country
        6.3.1 North America Female Contraceptive Sales by Country (2017-2028)
        6.3.2 North America Female Contraceptive Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Female Contraceptive Market Size by Type
        7.1.1 Europe Female Contraceptive Sales by Type (2017-2028)
        7.1.2 Europe Female Contraceptive Revenue by Type (2017-2028)
    7.2 Europe Female Contraceptive Market Size by Application
        7.2.1 Europe Female Contraceptive Sales by Application (2017-2028)
        7.2.2 Europe Female Contraceptive Revenue by Application (2017-2028)
    7.3 Europe Female Contraceptive Market Size by Country
        7.3.1 Europe Female Contraceptive Sales by Country (2017-2028)
        7.3.2 Europe Female Contraceptive Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Female Contraceptive Market Size by Type
        8.1.1 Asia Pacific Female Contraceptive Sales by Type (2017-2028)
        8.1.2 Asia Pacific Female Contraceptive Revenue by Type (2017-2028)
    8.2 Asia Pacific Female Contraceptive Market Size by Application
        8.2.1 Asia Pacific Female Contraceptive Sales by Application (2017-2028)
        8.2.2 Asia Pacific Female Contraceptive Revenue by Application (2017-2028)
    8.3 Asia Pacific Female Contraceptive Market Size by Region
        8.3.1 Asia Pacific Female Contraceptive Sales by Region (2017-2028)
        8.3.2 Asia Pacific Female Contraceptive Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Female Contraceptive Market Size by Type
        9.1.1 Latin America Female Contraceptive Sales by Type (2017-2028)
        9.1.2 Latin America Female Contraceptive Revenue by Type (2017-2028)
    9.2 Latin America Female Contraceptive Market Size by Application
        9.2.1 Latin America Female Contraceptive Sales by Application (2017-2028)
        9.2.2 Latin America Female Contraceptive Revenue by Application (2017-2028)
    9.3 Latin America Female Contraceptive Market Size by Country
        9.3.1 Latin America Female Contraceptive Sales by Country (2017-2028)
        9.3.2 Latin America Female Contraceptive Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Female Contraceptive Market Size by Type
        10.1.1 Middle East and Africa Female Contraceptive Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Female Contraceptive Revenue by Type (2017-2028)
    10.2 Middle East and Africa Female Contraceptive Market Size by Application
        10.2.1 Middle East and Africa Female Contraceptive Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Female Contraceptive Revenue by Application (2017-2028)
    10.3 Middle East and Africa Female Contraceptive Market Size by Country
        10.3.1 Middle East and Africa Female Contraceptive Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Female Contraceptive Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Allergan
        11.3.1 Allergan Corporation Information
        11.3.2 Allergan Overview
        11.3.3 Allergan Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Allergan Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Allergan Recent Developments
    11.4 Bayer
        11.4.1 Bayer Corporation Information
        11.4.2 Bayer Overview
        11.4.3 Bayer Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bayer Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bayer Recent Developments
    11.5 Okamoto Industries
        11.5.1 Okamoto Industries Corporation Information
        11.5.2 Okamoto Industries Overview
        11.5.3 Okamoto Industries Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Okamoto Industries Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Okamoto Industries Recent Developments
    11.6 Reckitt Benckiser
        11.6.1 Reckitt Benckiser Corporation Information
        11.6.2 Reckitt Benckiser Overview
        11.6.3 Reckitt Benckiser Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Reckitt Benckiser Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Reckitt Benckiser Recent Developments
    11.7 Lupin Pharmaceuticals
        11.7.1 Lupin Pharmaceuticals Corporation Information
        11.7.2 Lupin Pharmaceuticals Overview
        11.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Lupin Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Lupin Pharmaceuticals Recent Developments
    11.8 Foundation Consumer Healthcare
        11.8.1 Foundation Consumer Healthcare Corporation Information
        11.8.2 Foundation Consumer Healthcare Overview
        11.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Foundation Consumer Healthcare Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Foundation Consumer Healthcare Recent Developments
    11.9 Teva Pharmaceuticals
        11.9.1 Teva Pharmaceuticals Corporation Information
        11.9.2 Teva Pharmaceuticals Overview
        11.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teva Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teva Pharmaceuticals Recent Developments
    11.10 Ansell
        11.10.1 Ansell Corporation Information
        11.10.2 Ansell Overview
        11.10.3 Ansell Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Ansell Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Ansell Recent Developments
    11.11 Ferring Pharmaceuticals
        11.11.1 Ferring Pharmaceuticals Corporation Information
        11.11.2 Ferring Pharmaceuticals Overview
        11.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Ferring Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Ferring Pharmaceuticals Recent Developments
    11.12 Fuji Latex
        11.12.1 Fuji Latex Corporation Information
        11.12.2 Fuji Latex Overview
        11.12.3 Fuji Latex Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Fuji Latex Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Fuji Latex Recent Developments
    11.13 Janssen Pharmaceuticals
        11.13.1 Janssen Pharmaceuticals Corporation Information
        11.13.2 Janssen Pharmaceuticals Overview
        11.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Janssen Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Janssen Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Female Contraceptive Industry Chain Analysis
    12.2 Female Contraceptive Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Female Contraceptive Production Mode & Process
    12.4 Female Contraceptive Sales and Marketing
        12.4.1 Female Contraceptive Sales Channels
        12.4.2 Female Contraceptive Distributors
    12.5 Female Contraceptive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Female Contraceptive Industry Trends
    13.2 Female Contraceptive Market Drivers
    13.3 Female Contraceptive Market Challenges
    13.4 Female Contraceptive Market Restraints
14 Key Findings in The Global Female Contraceptive Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Female Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Female Contraceptive Devices
    Table 3. Major Manufacturers of Female Contraceptive Drugs
    Table 4. Global Female Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Female Contraceptive Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Female Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 7. Global Female Contraceptive Sales Market Share by Region (2017-2022)
    Table 8. Global Female Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 9. Global Female Contraceptive Sales Market Share by Region (2023-2028)
    Table 10. Global Female Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Female Contraceptive Revenue Market Share by Region (2017-2022)
    Table 12. Global Female Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Female Contraceptive Revenue Market Share by Region (2023-2028)
    Table 14. Global Female Contraceptive Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Female Contraceptive Sales Share by Manufacturers (2017-2022)
    Table 16. Global Female Contraceptive Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Female Contraceptive Revenue Share by Manufacturers (2017-2022)
    Table 18. Female Contraceptive Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Female Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Female Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptive as of 2021)
    Table 21. Female Contraceptive Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Female Contraceptive Product Offered
    Table 23. Date of Manufacturers Enter into Female Contraceptive Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 26. Global Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 27. Global Female Contraceptive Sales Share by Type (2017-2022)
    Table 28. Global Female Contraceptive Sales Share by Type (2023-2028)
    Table 29. Global Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Female Contraceptive Revenue Share by Type (2017-2022)
    Table 32. Global Female Contraceptive Revenue Share by Type (2023-2028)
    Table 33. Female Contraceptive Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Female Contraceptive Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 36. Global Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 37. Global Female Contraceptive Sales Share by Application (2017-2022)
    Table 38. Global Female Contraceptive Sales Share by Application (2023-2028)
    Table 39. Global Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Female Contraceptive Revenue Share by Application (2017-2022)
    Table 42. Global Female Contraceptive Revenue Share by Application (2023-2028)
    Table 43. Female Contraceptive Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Female Contraceptive Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 46. North America Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 47. North America Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 50. North America Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 51. North America Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Female Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 54. North America Female Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 55. North America Female Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Female Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Female Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Female Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Female Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Female Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Female Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Female Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Female Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Female Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Female Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Female Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Female Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Female Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Female Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Female Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Female Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Female Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Female Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Female Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Female Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Female Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Female Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Female Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Female Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Female Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Merck Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. Pfizer Corporation Information
    Table 111. Pfizer Description and Major Businesses
    Table 112. Pfizer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Pfizer Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Pfizer Recent Developments
    Table 115. Allergan Corporation Information
    Table 116. Allergan Description and Major Businesses
    Table 117. Allergan Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Allergan Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Allergan Recent Developments
    Table 120. Bayer Corporation Information
    Table 121. Bayer Description and Major Businesses
    Table 122. Bayer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Bayer Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Bayer Recent Developments
    Table 125. Okamoto Industries Corporation Information
    Table 126. Okamoto Industries Description and Major Businesses
    Table 127. Okamoto Industries Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Okamoto Industries Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Okamoto Industries Recent Developments
    Table 130. Reckitt Benckiser Corporation Information
    Table 131. Reckitt Benckiser Description and Major Businesses
    Table 132. Reckitt Benckiser Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Reckitt Benckiser Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Reckitt Benckiser Recent Developments
    Table 135. Lupin Pharmaceuticals Corporation Information
    Table 136. Lupin Pharmaceuticals Description and Major Businesses
    Table 137. Lupin Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Lupin Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Lupin Pharmaceuticals Recent Developments
    Table 140. Foundation Consumer Healthcare Corporation Information
    Table 141. Foundation Consumer Healthcare Description and Major Businesses
    Table 142. Foundation Consumer Healthcare Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Foundation Consumer Healthcare Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Foundation Consumer Healthcare Recent Developments
    Table 145. Teva Pharmaceuticals Corporation Information
    Table 146. Teva Pharmaceuticals Description and Major Businesses
    Table 147. Teva Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Teva Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Teva Pharmaceuticals Recent Developments
    Table 150. Ansell Corporation Information
    Table 151. Ansell Description and Major Businesses
    Table 152. Ansell Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Ansell Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Ansell Recent Developments
    Table 155. Ferring Pharmaceuticals Corporation Information
    Table 156. Ferring Pharmaceuticals Description and Major Businesses
    Table 157. Ferring Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Ferring Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Ferring Pharmaceuticals Recent Developments
    Table 160. Fuji Latex Corporation Information
    Table 161. Fuji Latex Description and Major Businesses
    Table 162. Fuji Latex Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Fuji Latex Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Fuji Latex Recent Developments
    Table 165. Janssen Pharmaceuticals Corporation Information
    Table 166. Janssen Pharmaceuticals Description and Major Businesses
    Table 167. Janssen Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 168. Janssen Pharmaceuticals Female Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Janssen Pharmaceuticals Recent Developments
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Female Contraceptive Distributors List
    Table 173. Female Contraceptive Customers List
    Table 174. Female Contraceptive Market Trends
    Table 175. Female Contraceptive Market Drivers
    Table 176. Female Contraceptive Market Challenges
    Table 177. Female Contraceptive Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Female Contraceptive Product Picture
    Figure 3. Global Female Contraceptive Market Share by Type in 2021 & 2028
    Figure 3. Female Contraceptive Devices Product Picture
    Figure 4. Female Contraceptive Drugs Product Picture
    Figure 5. Global Female Contraceptive Market Share by Application in 2021 & 2028
    Figure 6. Online Stores
    Figure 7. Retail Outlets
    Figure 8. Female Contraceptive Report Years Considered
    Figure 9. Global Female Contraceptive Sales 2017-2028 (K Units)
    Figure 10. Global Female Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Female Contraceptive Revenue 2017-2028 (US$ Million)
    Figure 12. Global Female Contraceptive Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Female Contraceptive Sales Market Share by Region (2017-2022)
    Figure 14. Global Female Contraceptive Sales Market Share by Region (2023-2028)
    Figure 15. North America Female Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Female Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Female Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Female Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Female Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Female Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Female Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Female Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Female Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Female Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Female Contraceptive Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Female Contraceptive in the World: Market Share by Female Contraceptive Revenue in 2021
    Figure 27. Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 29. Global Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 30. Global Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 31. Global Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 32. North America Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 33. North America Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 34. North America Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 35. North America Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 36. North America Female Contraceptive Sales Share by Country (2017-2028)
    Figure 37. North America Female Contraceptive Revenue Share by Country (2017-2028)
    Figure 38. U.S. Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 41. Europe Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 43. Europe Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Female Contraceptive Sales Share by Country (2017-2028)
    Figure 45. Europe Female Contraceptive Revenue Share by Country (2017-2028)
    Figure 46. Germany Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 47. France Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Female Contraceptive Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Female Contraceptive Revenue Share by Region (2017-2028)
    Figure 57. China Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 60. India Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Female Contraceptive Sales Share by Country (2017-2028)
    Figure 72. Latin America Female Contraceptive Revenue Share by Country (2017-2028)
    Figure 73. Mexico Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Female Contraceptive Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Female Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Female Contraceptive Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Female Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Female Contraceptive Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Female Contraceptive Revenue Share by Country (2017-2028)
    Figure 82. Turkey Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Female Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 85. Female Contraceptive Value Chain
    Figure 86. Female Contraceptive Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Frequently Asked Questions
Female Contraceptive report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Female Contraceptive report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Female Contraceptive report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Female Sex Toys

Female Sex Toys market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More